Skip to main content

Security report for astrazeneca.fr

AstraZeneca · Healthcare · France

Medium risk. 3 critical or high findings in Security headers, SSL/TLS and 1 other check.

Security score

71/100

Risk levelMedium

0–100, higher is better. How it is calculated

AstraZeneca France operates as a regional branch of the global biopharmaceutical company AstraZeneca, focusing on research, development, production, and commercialization of prescription medicines across key therapeutic areas including oncology, cardiovascular, respiratory, vaccines, and rare diseases. The website targets French residents, patients, healthcare professionals, and stakeholders, providing comprehensive information about the company's products, innovation strategies, and corporate social responsibility initiatives. The site is professionally designed with clear navigation and mobile optimization, reflecting a mature digital presence. Technically, the website leverages modern web technologies including Adobe Experience Manager CMS, JavaScript libraries like jQuery, and analytics platforms such as Matomo and Adobe Analytics. Tag management is handled via Tealium, and security is enhanced through Cloudflare services including rate limiting and bot management. The site employs HTTPS with strong SSL configuration and cookie consent mechanisms, demonstrating compliance with GDPR and French data protection regulations. Security posture is robust with no evident vulnerabilities or exposed sensitive data. However, explicit security headers like X-Frame-Options and X-Content-Type-Options should be verified. The absence of WHOIS data is noted but likely due to registry policies rather than malicious intent. Overall, the site maintains high trustworthiness and professionalism. Strategically, AstraZeneca France should continue to monitor third-party scripts for vulnerabilities, enhance transparency around incident response and security policies, and ensure all forms are secured against common web threats. These measures will strengthen compliance and user trust in an increasingly regulated healthcare digital environment.

Scanned

NIS2 and GDPR posture

GDPR outside view
83/ 100 · Low
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

3 findings rated critical or high. Fix these first.

  1. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

  2. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1

  3. DNS health

    DNS sends visitors and email to the right servers. Misconfigured records can cause outages or let someone redirect your traffic.

    • High

      Unregistered MX Record

      MX record points to unregistered domain: mailhub.medcost.fr

      What to do: Remove or fix MX record pointing to unregistered domain

      • RFC 5321 §5.1
      • NIS2 21(2)(i)
      • IR 2024/2690 12.4: Implementing Regulation (EU) 2024/2690, Annex point 12.4: Asset inventory
      • NIST CM-8: NIST SP 800-53 Rev. 5 CM-8: System Component Inventory

Need hands-on remediation? Email guard@offseq.com

Keep watching astrazeneca.fr

This scan found 22 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
72
Security headers
55
Email security
70
DNS health
45
Network security
100
GDPR outside view
83
Average
71

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

AstraZeneca France holds a strong market position as a leading biopharmaceutical entity in France, aligned with the global AstraZeneca brand. Its business model centers on innovative drug development and patient-centric healthcare solutions across multiple therapeutic areas. The company benefits from a broad portfolio and ongoing pipeline development, supported by strategic partnerships and a culture of innovation. The website reflects a focus on corporate social responsibility, employee engagement, and patient support, indicating a comprehensive ecosystem approach. Growth indicators include recognition in global rankings and active recruitment efforts. The partnership ecosystem includes global AstraZeneca sites and specialized healthcare platforms.

Security posture

The website demonstrates a mature security posture with enforced HTTPS, use of Cloudflare for bot and rate limiting protections, and cookie consent mechanisms aligned with GDPR. Analytics and marketing tools are deployed with privacy considerations. No critical vulnerabilities or exposed sensitive data were detected in the HTML content. However, explicit publication of security policies, incident response procedures, and vulnerability disclosure programs is absent, representing an area for improvement. The lack of WHOIS transparency is noted but does not currently impact operational security. Overall, the security culture appears proactive but could benefit from enhanced transparency and formalized incident response communication.

Recommendations

  1. Verify and explicitly implement security headers such as X-Frame-Options and X-Content-Type-Options to mitigate clickjacking and MIME sniffing risks.
  2. Publish clear security policies and incident response procedures on the website to enhance transparency and user trust.
  3. Implement and publicize a vulnerability disclosure program or security.txt file to encourage responsible reporting of security issues.
  4. Regularly audit third-party scripts and analytics tools to ensure they do not introduce vulnerabilities or privacy risks.
  5. Enhance contact information availability, including dedicated security and data protection officer contacts, to improve compliance and stakeholder communication.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
AstraZeneca
Description
Groupe Biopharmaceutique international guidé par la science mettant à disposition des médicaments innovants qui changent la vie des patients.
Key services
Cardiovascular, Renal & Metabolism treatments, Oncology medicines, Respiratory & Immunology treatments, Vaccines and immune therapies, Rare diseases treatments
Content quality
excellent
Branding
consistent

Technology

Stack
JavaScript, jQuery, Matomo Analytics, Tealium Tag Management, Adobe Analytics, Cloudflare (rate limiting and bot management), Responsive images, HTML5, CSS3
Platforms
Matomo Cloud, Tealium, Cloudflare
Performance
moderate
Mobile
excellent
Accessibility
good
SEO
good

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced
  • Use of Cloudflare rate limiting and bot management cookies
  • Cookie consent mechanism implemented
  • No exposed sensitive data found in HTML

Analytics and tracking

Services
Matomo, Adobe Analytics
Tracking level
moderate
Privacy practices
good

Advertising

Ad networks
Flashtalking
Tracking pixels
Adobe Analytics, Matomo
Marketing tools
Tealium, Adobe Audience Manager
Transparency
good

Site quality

Design
excellent
User experience
excellent
Content relevance
excellent
Navigation
excellent
Professionalism
excellent
Trustworthiness
high

Key observations

  1. Website is fully accessible with rich content and navigation.
  2. Strong focus on pharmaceutical and healthcare information.
  3. Comprehensive cookie and privacy policies with consent mechanisms.
  4. Use of modern analytics and tag management tools.
  5. No contact emails or phone numbers explicitly found in the HTML content.
  6. Social media presence limited to LinkedIn link.
  7. No explicit security or incident response policies published on site.
  8. WHOIS data unavailable, which is unusual but not uncommon for French domains.
Technical notes

Notes

The website is built on Adobe Experience Manager CMS, leveraging modern JavaScript libraries and responsive design techniques for optimal user experience across devices. Analytics are managed through Matomo and Adobe Analytics, with tag management via Tealium. Hosting and security are supported by Cloudflare and AWS infrastructure. Performance is moderate with room for optimization, particularly in script loading and image delivery. Accessibility features are present but could be further enhanced. SEO practices are good with proper meta tags and structured data. Technical risks are minimal but include dependency on multiple third-party services which require ongoing monitoring.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with astrazeneca.fr. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review astrazeneca.fr.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.